|
|
|
Word Search (Top 10 - by date)
|
Injex Pharma AG Announces Changes to It's Executive Management Board
Biomatrica
(May 17, 2013)
|
| Harbor Island Development Corp. Announces Strong Response for the NxUltra Campaign in Support of Further Expansion of Marketing Efforts
(May 17, 2013)
|
Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results
Sinovac Biotech
(May 17, 2013)
|
XenoPort Provides Update on Availability of Horizant
XenoPort
(May 17, 2013)
|
| Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd
(May 17, 2013)
|
| Yongye International Provides Update on Status of Proposed Go Private Offer
(May 17, 2013)
|
Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
Sanofi
(May 17, 2013)
|
Medigus: Successful Three-Year Follow-Up Data of the SRS™ Pivotal Study in Indiana University Will be Presented at the Digestive Disease Week in Orlando
MediGus
(May 16, 2013)
|
Biosensors to Acquire Assets of Spectrum Dynamics
Biosensors International
(May 16, 2013)
|
Novelos Therapeutics Provides Product Pipeline Update
Novelos Therapeutics
(May 16, 2013)
|
|
|
|
|
EvaluatePharma® - the premier source for pharma and biotech analysis.
Expert integration of financial and product data across historic and forecast timeframes (1986 to 2016) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, patent status (expiry date/ number), deals (upfront/ milestones), license revenues (royalties/ co-promotion) and much more.
|
|
Clinical Trial Coverage: No. of Trials involving Product
|
|
Trial Count
|
| Ambien IR/Stilnox/Myslee1 |
96 |
|
|
Welcome
Evaluate provides market intelligence and analysis for the pharma, biotech and medtech industries.
Explore Evaluate
Partnering
EvaluatePharma® now includes Partnering Opportunities - products available for licensing.
Partnering Opportunities in EvaluatePharma® are sourced from the rights holders - all entries are verified by the team of Analysts at EvaluatePharma - and presented in their commercial context.
Register to submit your Partnering Opportunities or to see your own and other Partnering Opportunities in their commercial context with the unique industry-wide analysis in EvaluatePharma®.
Take a full subscription to see all products available for license, including updated contact details for the out-licensing entity.
Register to access more FREE content:
- 2011 Product Sales analysis
- Download analysis into Excel
- Search 2 yrs of company press releases
|
Research Codes Synonyms
|
| Product: |
Ambien IR/Stilnox/Myslee |
|
Register for Free Analysis
Register to access more free insights and analysis from Evaluate.
Register Now
|
|
|
|